SIMILAR PATTERNS OF AMINO ACIDS FOR 1XWF_D_ADND433
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ccr | CYTOCHROME C (Oryza sativa) |
PF00034(Cytochrom_C) | 5 | THR A 71ASP A 60HIS A 26LEU A 40LEU A 43 | NoneHEM A 112 (-3.6A)HEM A 112 (-3.2A)NoneNone | 1.15A | 1xwfD-1ccrA:undetectable | 1xwfD-1ccrA:14.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uan | HYPOTHETICAL PROTEINTT1542 (Thermusthermophilus) |
PF02585(PIG-L) | 5 | HIS A 10THR A 38GLU A 41ASP A 12GLY A 75 | None | 1.20A | 1xwfD-1uanA:2.2 | 1xwfD-1uanA:19.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | GLU A 58ASP A 234LEU A 389LEU A 392GLY A 397MET A 403PHE A 407 | ADN A 502 (-3.6A)ADN A 502 (-2.8A)NAD A 501 ( 3.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.7A)ADN A 502 (-3.6A)None | 0.95A | 1xwfD-1v8bA:49.9 | 1xwfD-1v8bA:52.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 53HIS A 54GLU A 58ASP A 134ASP A 234LEU A 392GLY A 397MET A 403PHE A 407 | NoneADN A 502 (-4.1A)ADN A 502 (-3.6A)ADN A 502 (-3.1A)ADN A 502 (-2.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.7A)ADN A 502 (-3.6A)None | 1.01A | 1xwfD-1v8bA:49.9 | 1xwfD-1v8bA:52.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 53HIS A 54THR A 56GLU A 58ASP A 134ASP A 234GLY A 397MET A 403PHE A 407 | NoneADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-3.6A)ADN A 502 (-3.1A)ADN A 502 (-2.8A)ADN A 502 ( 3.7A)ADN A 502 (-3.6A)None | 0.83A | 1xwfD-1v8bA:49.9 | 1xwfD-1v8bA:52.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | THR A 56GLU A 58ASP A 234LEU A 389GLY A 397MET A 403PHE A 407 | ADN A 502 (-3.0A)ADN A 502 (-3.6A)ADN A 502 (-2.8A)NAD A 501 ( 3.8A)ADN A 502 ( 3.7A)ADN A 502 (-3.6A)None | 0.96A | 1xwfD-1v8bA:49.9 | 1xwfD-1v8bA:52.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xnf | LIPOPROTEIN NLPI (Escherichiacoli) |
PF07719(TPR_2)PF13181(TPR_8) | 5 | THR A 107ASP A 120LEU A 148LEU A 140GLY A 137 | None | 1.08A | 1xwfD-1xnfA:undetectable | 1xwfD-1xnfA:23.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y23 | HISTIDINE TRIADPROTEIN (Bacillussubtilis) |
PF01230(HIT) | 5 | LEU A 43HIS A 104ASP A 33GLY A 95PHE A 9 | None | 1.14A | 1xwfD-1y23A:undetectable | 1xwfD-1y23A:16.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2c27 | MYCOTHIOL SYNTHASE (Mycobacteriumtuberculosis) |
PF00583(Acetyltransf_1) | 5 | LEU A 127THR A 121LEU A 65LEU A 80GLY A 92 | NoneACO A1313 (-3.6A)NoneACO A1313 (-4.2A)ACO A1313 (-3.4A) | 1.05A | 1xwfD-2c27A:undetectable | 1xwfD-2c27A:22.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ph7 | UNCHARACTERIZEDPROTEIN AF_2093 (Archaeoglobusfulgidus) |
no annotation | 5 | LEU A 196HIS A 156GLU A 162LEU A 33GLY A 37 | None | 1.20A | 1xwfD-2ph7A:undetectable | 1xwfD-2ph7A:19.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2y8u | CHITIN DEACETYLASE (Aspergillusnidulans) |
PF01522(Polysacc_deac_1) | 5 | LEU A 73HIS A 97THR A 98ASP A 48LEU A 139 | None CO A1239 ( 3.3A)None CO A1239 ( 2.4A)PO4 A1238 ( 4.8A) | 1.05A | 1xwfD-2y8uA:3.2 | 1xwfD-2y8uA:19.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 252LEU A 407LEU A 410GLY A 415MET A 421 | ADN A 500 (-2.7A)NAD A 550 (-4.2A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A) | 1.06A | 1xwfD-3ce6A:50.2 | 1xwfD-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 363LEU A 407LEU A 410GLY A 415MET A 421 | ADN A 500 ( 3.7A)NAD A 550 (-4.2A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A) | 0.83A | 1xwfD-3ce6A:50.2 | 1xwfD-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 363LEU A 410GLY A 415MET A 421PHE A 425 | ADN A 500 ( 3.7A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.80A | 1xwfD-3ce6A:50.2 | 1xwfD-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 68HIS A 69ASP A 156ASP A 252LEU A 407PHE A 425 | NoneADN A 500 (-4.0A)ADN A 500 (-2.9A)ADN A 500 (-2.7A)NAD A 550 (-4.2A)ADN A 500 (-4.8A) | 1.37A | 1xwfD-3ce6A:50.2 | 1xwfD-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 68HIS A 69ASP A 156ASP A 252LEU A 410GLY A 415MET A 421PHE A 425 | NoneADN A 500 (-4.0A)ADN A 500 (-2.9A)ADN A 500 (-2.7A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 1.02A | 1xwfD-3ce6A:50.2 | 1xwfD-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 68HIS A 69THR A 71ASP A 156ASP A 252GLY A 415MET A 421PHE A 425 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-2.9A)ADN A 500 (-2.7A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.82A | 1xwfD-3ce6A:50.2 | 1xwfD-3ce6A:54.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 52HIS A 300LEU A 346GLY A 351MET A 357PHE A 361 | ADN A 438 (-4.0A)ADN A 438 ( 4.0A)ADN A 438 ( 4.8A)ADN A 438 ( 3.8A)ADN A 438 (-3.7A)None | 1.04A | 1xwfD-3g1uA:54.0 | 1xwfD-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 52THR A 54HIS A 300GLY A 351MET A 357PHE A 361 | ADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 ( 4.0A)ADN A 438 ( 3.8A)ADN A 438 (-3.7A)None | 0.96A | 1xwfD-3g1uA:54.0 | 1xwfD-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 300LEU A 343LEU A 346GLY A 351MET A 357 | ADN A 438 ( 4.0A)NAD A 439 ( 4.0A)ADN A 438 ( 4.8A)ADN A 438 ( 3.8A)ADN A 438 (-3.7A) | 0.80A | 1xwfD-3g1uA:54.0 | 1xwfD-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 51HIS A 52ASP A 130LEU A 343PHE A 361 | NoneADN A 438 (-4.0A)ADN A 438 (-4.1A)NAD A 439 ( 4.0A)None | 1.19A | 1xwfD-3g1uA:54.0 | 1xwfD-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 51HIS A 52ASP A 130LEU A 346GLY A 351MET A 357PHE A 361 | NoneADN A 438 (-4.0A)ADN A 438 (-4.1A)ADN A 438 ( 4.8A)ADN A 438 ( 3.8A)ADN A 438 (-3.7A)None | 0.96A | 1xwfD-3g1uA:54.0 | 1xwfD-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 51HIS A 52THR A 54ASP A 130GLY A 351MET A 357PHE A 361 | NoneADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-4.1A)ADN A 438 ( 3.8A)ADN A 438 (-3.7A)None | 0.71A | 1xwfD-3g1uA:54.0 | 1xwfD-3g1uA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 233LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 1.02A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 344LEU A 385LEU A 388GLY A 393MET A 399 | RAB A 602 ( 3.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A) | 0.73A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 344LEU A 388GLY A 393MET A 399PHE A 403 | RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.73A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 385PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)None | 1.27A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 61HIS A 62ASP A 139ASP A 233LEU A 388GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.98A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 61HIS A 62THR A 64ASP A 139ASP A 233GLY A 393MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.81A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | THR A 64HIS A 344GLY A 393MET A 399PHE A 403 | RAB A 602 (-2.7A)RAB A 602 ( 3.5A)RAB A 602 ( 3.8A)RAB A 602 (-3.6A)None | 0.79A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 189LEU A 343LEU A 346GLY A 351MET A 357PHE A 361 | NAD A 438 ( 4.4A)NAD A 438 (-4.0A)ADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 1.04A | 1xwfD-3h9uA:56.4 | 1xwfD-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 52HIS A 300LEU A 346GLY A 351MET A 357PHE A 361 | ADN A 439 ( 4.7A)NoneADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 1.09A | 1xwfD-3h9uA:56.4 | 1xwfD-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 52THR A 54HIS A 300GLY A 351MET A 357PHE A 361 | ADN A 439 ( 4.7A)ADN A 439 (-2.7A)NoneADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 1.02A | 1xwfD-3h9uA:56.4 | 1xwfD-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 300LEU A 343LEU A 346GLY A 351MET A 357PHE A 361 | NoneNAD A 438 (-4.0A)ADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 0.79A | 1xwfD-3h9uA:56.4 | 1xwfD-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 51HIS A 52ASP A 130ASP A 189LEU A 343PHE A 361 | NoneADN A 439 ( 4.7A)NoneNAD A 438 ( 4.4A)NAD A 438 (-4.0A)None | 1.39A | 1xwfD-3h9uA:56.4 | 1xwfD-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 51HIS A 52ASP A 130ASP A 189LEU A 346GLY A 351MET A 357PHE A 361 | NoneADN A 439 ( 4.7A)NoneNAD A 438 ( 4.4A)ADN A 439 ( 4.7A)ADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 0.97A | 1xwfD-3h9uA:56.4 | 1xwfD-3h9uA:71.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 51HIS A 52THR A 54ASP A 130ASP A 189GLY A 351MET A 357PHE A 361 | NoneADN A 439 ( 4.7A)ADN A 439 (-2.7A)NoneNAD A 438 ( 4.4A)ADN A 439 (-3.5A)ADN A 439 ( 3.7A)None | 0.82A | 1xwfD-3h9uA:56.4 | 1xwfD-3h9uA:71.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hp7 | HEMOLYSIN, PUTATIVE (Streptococcusthermophilus) |
PF01479(S4)PF01728(FtsJ) | 5 | LEU A 122THR A 93GLU A 52LEU A 70GLY A 66 | None | 1.03A | 1xwfD-3hp7A:5.1 | 1xwfD-3hp7A:22.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 226LEU A 378LEU A 381GLY A 386MET A 392 | ADN A 500 ( 2.6A)NAD A 550 (-4.3A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.7A) | 0.95A | 1xwfD-3n58A:52.5 | 1xwfD-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 55HIS A 337LEU A 381GLY A 386MET A 392PHE A 396 | ADN A 500 (-4.0A)ADN A 500 ( 3.6A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.7A)None | 1.04A | 1xwfD-3n58A:52.5 | 1xwfD-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 55THR A 57HIS A 337GLY A 386MET A 392PHE A 396 | ADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-3.7A)None | 0.98A | 1xwfD-3n58A:52.5 | 1xwfD-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 337LEU A 378LEU A 381GLY A 386MET A 392 | ADN A 500 ( 3.6A)NAD A 550 (-4.3A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.7A) | 0.72A | 1xwfD-3n58A:52.5 | 1xwfD-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 54HIS A 55ASP A 132ASP A 226LEU A 378PHE A 396 | NoneADN A 500 (-4.0A)ADN A 500 (-3.3A)ADN A 500 ( 2.6A)NAD A 550 (-4.3A)None | 1.30A | 1xwfD-3n58A:52.5 | 1xwfD-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 54HIS A 55ASP A 132ASP A 226LEU A 381GLY A 386MET A 392PHE A 396 | NoneADN A 500 (-4.0A)ADN A 500 (-3.3A)ADN A 500 ( 2.6A)ADN A 500 ( 4.8A)ADN A 500 (-3.7A)ADN A 500 (-3.7A)None | 0.96A | 1xwfD-3n58A:52.5 | 1xwfD-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 54HIS A 55THR A 57ASP A 132ASP A 226GLY A 386MET A 392PHE A 396 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.3A)ADN A 500 ( 2.6A)ADN A 500 (-3.7A)ADN A 500 (-3.7A)None | 0.78A | 1xwfD-3n58A:52.5 | 1xwfD-3n58A:58.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 62ASP A 139ASP A 239LEU A 398GLY A 403MET A 409PHE A 413 | ADE A 506 (-4.6A)NoneNAD A 501 ( 4.5A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 1.00A | 1xwfD-3oneA:49.4 | 1xwfD-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 62THR A 64ASP A 139ASP A 239GLY A 403MET A 409PHE A 413 | ADE A 506 (-4.6A)ADE A 506 (-2.8A)NoneNAD A 501 ( 4.5A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.82A | 1xwfD-3oneA:49.4 | 1xwfD-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61ASP A 239LEU A 395LEU A 398GLY A 403MET A 409 | NoneNAD A 501 ( 4.5A)NAD A 501 (-4.2A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A) | 1.05A | 1xwfD-3oneA:49.4 | 1xwfD-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61ASP A 239LEU A 398GLY A 403MET A 409PHE A 413 | NoneNAD A 501 ( 4.5A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.98A | 1xwfD-3oneA:49.4 | 1xwfD-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61HIS A 350LEU A 395LEU A 398GLY A 403MET A 409 | NoneNoneNAD A 501 (-4.2A)ADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A) | 0.90A | 1xwfD-3oneA:49.4 | 1xwfD-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61HIS A 350LEU A 398GLY A 403MET A 409PHE A 413 | NoneNoneADE A 506 ( 4.7A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.91A | 1xwfD-3oneA:49.4 | 1xwfD-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61THR A 64ASP A 239GLY A 403MET A 409PHE A 413 | NoneADE A 506 (-2.8A)NAD A 501 ( 4.5A)ADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.87A | 1xwfD-3oneA:49.4 | 1xwfD-3oneA:57.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 61THR A 64HIS A 350GLY A 403MET A 409PHE A 413 | NoneADE A 506 (-2.8A)NoneADE A 506 ( 3.6A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.97A | 1xwfD-3oneA:49.4 | 1xwfD-3oneA:57.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l8l | 3-DEHYDROQUINATEDEHYDRATASE 1 (Pseudomonasaeruginosa) |
PF01220(DHquinase_II) | 5 | HIS A 8GLU A 36LEU A 15LEU A 28GLY A 29 | None | 1.08A | 1xwfD-4l8lA:4.2 | 1xwfD-4l8lA:15.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 342LEU A 383LEU A 386GLY A 391MET A 397PHE A 401 | ADN A 501 ( 3.7A)NAD A 503 ( 3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.77A | 1xwfD-4lvcA:52.0 | 1xwfD-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57ASP A 231LEU A 383LEU A 386GLY A 391PHE A 401 | NoneADN A 501 (-3.1A)NAD A 503 ( 3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-4.8A) | 1.10A | 1xwfD-4lvcA:52.0 | 1xwfD-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58ASP A 135ASP A 231LEU A 386GLY A 391PHE A 401 | NoneADN A 501 (-4.0A)ADN A 501 (-3.0A)ADN A 501 (-3.1A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-4.8A) | 1.00A | 1xwfD-4lvcA:52.0 | 1xwfD-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58ASP A 135LEU A 386GLY A 391MET A 397PHE A 401 | NoneADN A 501 (-4.0A)ADN A 501 (-3.0A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.80A | 1xwfD-4lvcA:52.0 | 1xwfD-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58THR A 60ASP A 135ASP A 231GLY A 391PHE A 401 | NoneADN A 501 (-4.0A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-3.1A)ADN A 501 (-3.6A)ADN A 501 (-4.8A) | 0.87A | 1xwfD-4lvcA:52.0 | 1xwfD-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58THR A 60ASP A 135GLY A 391MET A 397PHE A 401 | NoneADN A 501 (-4.0A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.57A | 1xwfD-4lvcA:52.0 | 1xwfD-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57LEU A 383LEU A 386GLY A 391MET A 397PHE A 401 | NoneNAD A 503 ( 3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.85A | 1xwfD-4lvcA:52.0 | 1xwfD-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57THR A 60ASP A 231LEU A 383GLY A 391PHE A 401 | NoneADN A 501 (-2.8A)ADN A 501 (-3.1A)NAD A 503 ( 3.9A)ADN A 501 (-3.6A)ADN A 501 (-4.8A) | 1.10A | 1xwfD-4lvcA:52.0 | 1xwfD-4lvcA:58.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57THR A 60LEU A 383GLY A 391MET A 397PHE A 401 | NoneADN A 501 (-2.8A)NAD A 503 ( 3.9A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.78A | 1xwfD-4lvcA:52.0 | 1xwfD-4lvcA:58.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lki | TCDA1 (Photorhabdusluminescens) |
PF03538(VRP1) | 5 | LEU A1613THR A1607GLU A1634LEU A1766GLY A1762 | None | 1.20A | 1xwfD-5lkiA:undetectable | 1xwfD-5lkiA:10.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | GLU A 57ASP A 245LEU A 401LEU A 404GLY A 409MET A 415PHE A 419 | SAH A 502 (-3.7A)SAH A 502 (-2.8A)NAD A 501 (-4.1A)SAH A 502 ( 4.7A)SAH A 502 ( 3.7A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.96A | 1xwfD-5utuA:48.3 | 1xwfD-5utuA:48.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 52HIS A 53GLU A 57ASP A 137ASP A 245LEU A 404GLY A 409MET A 415PHE A 419 | NoneSAH A 502 (-4.0A)SAH A 502 (-3.7A)SAH A 502 (-3.4A)SAH A 502 (-2.8A)SAH A 502 ( 4.7A)SAH A 502 ( 3.7A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.98A | 1xwfD-5utuA:48.3 | 1xwfD-5utuA:48.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 52HIS A 53THR A 55GLU A 57ASP A 137ASP A 245GLY A 409MET A 415PHE A 419 | NoneSAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-3.7A)SAH A 502 (-3.4A)SAH A 502 (-2.8A)SAH A 502 ( 3.7A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.82A | 1xwfD-5utuA:48.3 | 1xwfD-5utuA:48.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | THR A 55GLU A 57ASP A 245LEU A 401GLY A 409MET A 415PHE A 419 | SAH A 502 (-2.7A)SAH A 502 (-3.7A)SAH A 502 (-2.8A)NAD A 501 (-4.1A)SAH A 502 ( 3.7A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.95A | 1xwfD-5utuA:48.3 | 1xwfD-5utuA:48.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | ASP A 231LEU A 386LEU A 389GLY A 394MET A 400PHE A 404 | ADN A 502 (-2.8A)NAD A 501 (-3.9A)ADN A 502 ( 4.7A)ADN A 502 (-3.7A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.94A | 1xwfD-5v96A:51.4 | 1xwfD-5v96A:57.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | GLU A 63ASP A 231LEU A 386GLY A 394MET A 400PHE A 404 | ADN A 502 (-3.6A)ADN A 502 (-2.8A)NAD A 501 (-3.9A)ADN A 502 (-3.7A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.96A | 1xwfD-5v96A:51.4 | 1xwfD-5v96A:57.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 58HIS A 59ASP A 136ASP A 231LEU A 389GLY A 394MET A 400PHE A 404 | NoneADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 ( 4.7A)ADN A 502 (-3.7A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.99A | 1xwfD-5v96A:51.4 | 1xwfD-5v96A:57.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 58HIS A 59THR A 61GLU A 63ASP A 136ASP A 231GLY A 394MET A 400PHE A 404 | NoneADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-3.6A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)ADN A 502 (-3.7A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.85A | 1xwfD-5v96A:51.4 | 1xwfD-5v96A:57.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | GLU A 59ASP A 131ASP A 190GLY A 352MET A 358PHE A 362 | 9W4 A 502 (-3.8A)NoneNAD A 501 (-4.1A)9W4 A 502 ( 3.9A)9W4 A 502 (-3.6A)None | 0.76A | 1xwfD-5w4bA:58.9 | 1xwfD-5w4bA:96.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | GLU A 59ASP A 190LEU A 344LEU A 347GLY A 352MET A 358PHE A 362 | 9W4 A 502 (-3.8A)NAD A 501 (-4.1A)NAD A 501 (-4.0A)9W4 A 502 (-4.1A)9W4 A 502 ( 3.9A)9W4 A 502 (-3.6A)None | 0.61A | 1xwfD-5w4bA:58.9 | 1xwfD-5w4bA:96.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 54HIS A 55ASP A 131ASP A 190LEU A 347 | None9W4 A 502 (-3.7A)NoneNAD A 501 (-4.1A)9W4 A 502 (-4.1A) | 1.15A | 1xwfD-5w4bA:58.9 | 1xwfD-5w4bA:96.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 54HIS A 55THR A 57GLU A 59ASP A 131ASP A 190MET A 358PHE A 362 | None9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)9W4 A 502 (-3.8A)NoneNAD A 501 (-4.1A)9W4 A 502 (-3.6A)None | 0.58A | 1xwfD-5w4bA:58.9 | 1xwfD-5w4bA:96.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | THR A 57GLU A 59ASP A 190LEU A 347MET A 358PHE A 362 | 9W4 A 502 (-2.9A)9W4 A 502 (-3.8A)NAD A 501 (-4.1A)9W4 A 502 (-4.1A)9W4 A 502 (-3.6A)None | 0.71A | 1xwfD-5w4bA:58.9 | 1xwfD-5w4bA:96.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xgw | ISOASPARTYLDIPEPTIDASE (Colwelliapsychrerythraea) |
no annotation | 5 | HIS A 203ASP A 256HIS A 234LEU A 106GLY A 105 | NoneNone ZN A 402 (-3.3A)NoneNone | 1.21A | 1xwfD-5xgwA:2.4 | 1xwfD-5xgwA:12.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ydj | ACETYLCHOLINESTERASE (Anophelesgambiae) |
no annotation | 5 | LEU A 330HIS A 369LEU A 274GLY A 358PHE A 281 | None | 1.21A | 1xwfD-5ydjA:undetectable | 1xwfD-5ydjA:10.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yy3 | - (-) |
no annotation | 5 | HIS A 346ASP A 322HIS A 180LEU A 350GLY A 351 | None | 1.15A | 1xwfD-5yy3A:undetectable | 1xwfD-5yy3A:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 195LEU A 349LEU A 352GLY A 357MET A 363 | ADN A 501 (-2.7A)NAD A 500 ( 4.3A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 (-3.7A) | 1.03A | 1xwfD-6aphA:57.2 | 1xwfD-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 58HIS A 306LEU A 352GLY A 357MET A 363PHE A 367 | ADN A 501 (-3.9A)ADN A 501 ( 3.7A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)None | 1.04A | 1xwfD-6aphA:57.2 | 1xwfD-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | HIS A 58THR A 60HIS A 306GLY A 357MET A 363PHE A 367 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 ( 3.7A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)None | 0.95A | 1xwfD-6aphA:57.2 | 1xwfD-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 306LEU A 349LEU A 352GLY A 357MET A 363 | ADN A 501 ( 3.7A)NAD A 500 ( 4.3A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 (-3.7A) | 0.82A | 1xwfD-6aphA:57.2 | 1xwfD-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57HIS A 58ASP A 136ASP A 195LEU A 349PHE A 367 | NoneADN A 501 (-3.9A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)NAD A 500 ( 4.3A)None | 1.32A | 1xwfD-6aphA:57.2 | 1xwfD-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 57HIS A 58ASP A 136ASP A 195LEU A 352GLY A 357MET A 363PHE A 367 | NoneADN A 501 (-3.9A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)ADN A 501 ( 4.8A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)None | 0.98A | 1xwfD-6aphA:57.2 | 1xwfD-6aphA:66.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 57HIS A 58THR A 60ASP A 136ASP A 195GLY A 357MET A 363PHE A 367 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-2.7A)ADN A 501 (-3.6A)ADN A 501 (-3.7A)None | 0.81A | 1xwfD-6aphA:57.2 | 1xwfD-6aphA:66.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 5 | ASP B 198LEU B 373LEU B 376GLY B 381MET B 387 | ADN B 502 (-2.7A)NAD B 501 ( 3.9A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.7A) | 0.85A | 1xwfD-6f3mB:51.2 | 1xwfD-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 7 | HIS B 61ASP B 139ASP B 198LEU B 376GLY B 381MET B 387PHE B 391 | ADN B 502 ( 4.0A) ZN B 505 ( 2.5A)ADN B 502 (-2.7A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 1.05A | 1xwfD-6f3mB:51.2 | 1xwfD-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 7 | HIS B 61THR B 63ASP B 139ASP B 198GLY B 381MET B 387PHE B 391 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) ZN B 505 ( 2.5A)ADN B 502 (-2.7A)ADN B 502 ( 3.7A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.88A | 1xwfD-6f3mB:51.2 | 1xwfD-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 5 | HIS B 323LEU B 373LEU B 376GLY B 381MET B 387 | ZN B 505 (-3.2A)NAD B 501 ( 3.9A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.7A) | 0.67A | 1xwfD-6f3mB:51.2 | 1xwfD-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 5 | HIS B 323LEU B 376GLY B 381MET B 387PHE B 391 | ZN B 505 (-3.2A)ADN B 502 ( 4.8A)ADN B 502 ( 3.7A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.73A | 1xwfD-6f3mB:51.2 | 1xwfD-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | ASP A 193LEU A 347LEU A 350GLY A 355MET A 361PHE A 365 | ADN A 501 (-2.7A)NAD A 502 (-3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.97A | 1xwfD-6gbnA:57.3 | 1xwfD-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | HIS A 56HIS A 304LEU A 350GLY A 355MET A 361PHE A 365 | ADN A 501 (-3.9A)ADN A 501 ( 3.6A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 1.02A | 1xwfD-6gbnA:57.3 | 1xwfD-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | HIS A 56THR A 58HIS A 304GLY A 355MET A 361PHE A 365 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 ( 3.6A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.92A | 1xwfD-6gbnA:57.3 | 1xwfD-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | HIS A 304LEU A 347LEU A 350GLY A 355MET A 361PHE A 365 | ADN A 501 ( 3.6A)NAD A 502 (-3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.78A | 1xwfD-6gbnA:57.3 | 1xwfD-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 8 | LEU A 55HIS A 56ASP A 134ASP A 193LEU A 350GLY A 355MET A 361PHE A 365 | NoneADN A 501 (-3.9A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 ( 4.7A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.97A | 1xwfD-6gbnA:57.3 | 1xwfD-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 8 | LEU A 55HIS A 56THR A 58ASP A 134ASP A 193GLY A 355MET A 361PHE A 365 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.78A | 1xwfD-6gbnA:57.3 | 1xwfD-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | THR A 58ASP A 193LEU A 347GLY A 355MET A 361PHE A 365 | ADN A 501 (-2.8A)ADN A 501 (-2.7A)NAD A 502 (-3.9A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.96A | 1xwfD-6gbnA:57.3 | 1xwfD-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 6 | THR A 58HIS A 304LEU A 347GLY A 355MET A 361PHE A 365 | ADN A 501 (-2.8A)ADN A 501 ( 3.6A)NAD A 502 (-3.9A)ADN A 501 (-3.8A)ADN A 501 (-3.6A)None | 0.83A | 1xwfD-6gbnA:57.3 | 1xwfD-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1a6c | TOBACCO RINGSPOTVIRUS CAPSID PROTEIN (Tobaccoringspot virus) |
PF03391(Nepo_coat)PF03688(Nepo_coat_C)PF03689(Nepo_coat_N) | 3 | THR A 178GLU A 174HIS A 407 | None | 0.91A | 1xwfD-1a6cA:0.0 | 1xwfD-1a6cA:22.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dqu | ISOCITRATE LYASE (Aspergillusnidulans) |
PF00463(ICL) | 3 | THR A 82GLU A 491HIS A 501 | None | 0.90A | 1xwfD-1dquA:0.0 | 1xwfD-1dquA:21.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1f6d | UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE (Escherichiacoli) |
PF02350(Epimerase_2) | 3 | THR A 5GLU A 12HIS A 115 | None | 0.78A | 1xwfD-1f6dA:4.5 | 1xwfD-1f6dA:23.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kcw | CERULOPLASMIN (Homo sapiens) |
PF00394(Cu-oxidase)PF07731(Cu-oxidase_2)PF07732(Cu-oxidase_3) | 3 | THR A 837GLU A 823HIS A 816 | None | 0.76A | 1xwfD-1kcwA:0.0 | 1xwfD-1kcwA:17.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kcw | CERULOPLASMIN (Homo sapiens) |
PF00394(Cu-oxidase)PF07731(Cu-oxidase_2)PF07732(Cu-oxidase_3) | 3 | THR A1034GLU A 112HIS A 978 | NoneNone CU A1052 ( 3.2A) | 0.91A | 1xwfD-1kcwA:0.0 | 1xwfD-1kcwA:17.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1khw | RNA-DIRECTED RNAPOLYMERASE (Rabbithemorrhagicdisease virus) |
PF00680(RdRP_1) | 3 | THR A 16GLU A 78HIS A 290 | None | 0.91A | 1xwfD-1khwA:0.0 | 1xwfD-1khwA:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kvn | SRP19 (Archaeoglobusfulgidus) |
PF01922(SRP19) | 3 | THR A 8GLU A 61HIS A 35 | None | 0.39A | 1xwfD-1kvnA:0.0 | 1xwfD-1kvnA:12.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nyq | THREONYL-TRNASYNTHETASE 1 (Staphylococcusaureus) |
PF00587(tRNA-synt_2b)PF02824(TGS)PF03129(HGTP_anticodon)PF07973(tRNA_SAD) | 3 | THR A 523GLU A 484HIS A 243 | TSB A1002 (-2.9A)NoneNone | 0.80A | 1xwfD-1nyqA:2.1 | 1xwfD-1nyqA:19.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1p49 | STERYL-SULFATASE (Homo sapiens) |
PF00884(Sulfatase)PF14707(Sulfatase_C) | 3 | THR A 470GLU A 511HIS A 444 | None | 0.65A | 1xwfD-1p49A:1.1 | 1xwfD-1p49A:21.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xrz | ZINC FINGERY-CHROMOSOMALPROTEIN (Homo sapiens) |
PF13909(zf-H2C2_5) | 3 | THR A 2GLU A 9HIS A 21 | NoneALC A 10 ( 4.6A)ALC A 10 (-2.5A) | 0.90A | 1xwfD-1xrzA:undetectable | 1xwfD-1xrzA:5.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1yq2 | BETA-GALACTOSIDASE (Arthrobactersp. C2-2) |
PF02836(Glyco_hydro_2_C)PF02837(Glyco_hydro_2_N)PF02929(Bgal_small_N)PF16353(DUF4981) | 3 | THR A 445GLU A 468HIS A 396 | None | 0.76A | 1xwfD-1yq2A:undetectable | 1xwfD-1yq2A:17.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zwx | SPHINGOMYELINASE-C (Listeriaivanovii) |
PF03372(Exo_endo_phos) | 3 | THR A 186GLU A 204HIS A 151 | None | 0.73A | 1xwfD-1zwxA:undetectable | 1xwfD-1zwxA:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b9e | NOL1/NOP2/SUN DOMAINFAMILY, MEMBER 5ISOFORM 2 (Homo sapiens) |
PF01189(Methyltr_RsmB-F) | 3 | THR A 358GLU A 367HIS A 392 | None | 0.90A | 1xwfD-2b9eA:undetectable | 1xwfD-2b9eA:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dy3 | ALANINE RACEMASE (Corynebacteriumglutamicum) |
PF00842(Ala_racemase_C)PF01168(Ala_racemase_N) | 3 | THR A 157GLU A 169HIS A 128 | None | 0.91A | 1xwfD-2dy3A:undetectable | 1xwfD-2dy3A:24.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f17 | THIAMINPYROPHOSPHOKINASE 1 (Mus musculus) |
PF04263(TPK_catalytic)PF04265(TPK_B1_binding) | 3 | THR A 198GLU A 2HIS A 173 | None | 0.82A | 1xwfD-2f17A:2.5 | 1xwfD-2f17A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f9h | PTS SYSTEM, IIACOMPONENT (Enterococcusfaecalis) |
PF03829(PTSIIA_gutA) | 3 | THR A 85GLU A 21HIS A 38 | None | 0.54A | 1xwfD-2f9hA:undetectable | 1xwfD-2f9hA:16.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fqd | BLUE COPPER OXIDASECUEO (Escherichiacoli) |
PF00394(Cu-oxidase)PF07731(Cu-oxidase_2)PF07732(Cu-oxidase_3) | 3 | THR A 99GLU A 506HIS A 103 | NoneC2O A 602 ( 4.9A)C2O A 602 (-3.0A) | 0.73A | 1xwfD-2fqdA:undetectable | 1xwfD-2fqdA:23.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i6u | ORNITHINECARBAMOYLTRANSFERASE (Mycobacteriumtuberculosis) |
PF00185(OTCace)PF02729(OTCace_N) | 3 | THR A 223GLU A 288HIS A 128 | NoneNone CP A 500 (-4.3A) | 0.89A | 1xwfD-2i6uA:3.3 | 1xwfD-2i6uA:22.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2iuj | LIPOXYGENASE L-5 (Glycine max) |
PF00305(Lipoxygenase)PF01477(PLAT) | 3 | THR A 788GLU A 167HIS A 536 | None | 0.87A | 1xwfD-2iujA:undetectable | 1xwfD-2iujA:19.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oo3 | PROTEIN INVOLVED INCATABOLISM OFEXTERNAL DNA (Legionellapneumophila) |
PF04378(RsmJ) | 3 | THR A 23GLU A 251HIS A 31 | None | 0.72A | 1xwfD-2oo3A:2.8 | 1xwfD-2oo3A:22.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rb7 | PEPTIDASE,M20/M25/M40 FAMILY (Desulfovibrioalaskensis) |
PF01546(Peptidase_M20)PF07687(M20_dimer) | 3 | THR A 11GLU A 336HIS A 72 | None | 0.73A | 1xwfD-2rb7A:undetectable | 1xwfD-2rb7A:22.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2v0o | FCH DOMAIN ONLYPROTEIN 2 (Homo sapiens) |
PF00611(FCH) | 3 | THR A 32GLU A 206HIS A 27 | None | 0.91A | 1xwfD-2v0oA:undetectable | 1xwfD-2v0oA:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vpq | ACETYL-COACARBOXYLASE (Staphylococcusaureus) |
PF00289(Biotin_carb_N)PF02785(Biotin_carb_C)PF02786(CPSase_L_D2) | 3 | THR A 304GLU A 225HIS A 333 | None | 0.81A | 1xwfD-2vpqA:undetectable | 1xwfD-2vpqA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xkk | TOPOISOMERASE IV (Acinetobacterbaumannii) |
PF00521(DNA_topoisoIV)PF00986(DNA_gyraseB_C)PF01751(Toprim) | 3 | THR A1361GLU A1468HIS A1369 | None | 0.88A | 1xwfD-2xkkA:undetectable | 1xwfD-2xkkA:22.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3b9t | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Methylobacillusflagellatus) |
PF03069(FmdA_AmdA) | 3 | THR A 292GLU A 350HIS A 111 | NoneEDO A 494 (-3.5A)None | 0.78A | 1xwfD-3b9tA:undetectable | 1xwfD-3b9tA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cvr | INVASION PLASMIDANTIGEN (Shigellaflexneri) |
PF12468(TTSSLRR)PF14496(NEL) | 3 | THR A 322GLU A 447HIS A 221 | None | 0.87A | 1xwfD-3cvrA:undetectable | 1xwfD-3cvrA:22.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3f41 | PHYTASE (Mitsuokellamultacida) |
PF14566(PTPlike_phytase) | 3 | THR A 257GLU A 132HIS A 222 | None | 0.83A | 1xwfD-3f41A:undetectable | 1xwfD-3f41A:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3f41 | PHYTASE (Mitsuokellamultacida) |
PF14566(PTPlike_phytase) | 3 | THR A 555GLU A 432HIS A 520 | None | 0.86A | 1xwfD-3f41A:undetectable | 1xwfD-3f41A:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g8d | BIOTIN CARBOXYLASE (Escherichiacoli) |
PF00289(Biotin_carb_N)PF02785(Biotin_carb_C)PF02786(CPSase_L_D2) | 3 | THR A 304GLU A 227HIS A 333 | None | 0.83A | 1xwfD-3g8dA:5.2 | 1xwfD-3g8dA:23.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 3 | THR A 67GLU A 199HIS A 394 | RAB A 602 (-4.5A)RAB A 602 (-4.6A)NAD A 601 ( 3.6A) | 0.83A | 1xwfD-3glqA:52.7 | 1xwfD-3glqA:56.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hig | AMILORIDE-SENSITIVEAMINE OXIDASE (Homo sapiens) |
PF01179(Cu_amine_oxid)PF02727(Cu_amine_oxidN2)PF02728(Cu_amine_oxidN3) | 3 | THR A 369GLU A 218HIS A 362 | None | 0.87A | 1xwfD-3higA:undetectable | 1xwfD-3higA:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3id6 | PRE MRNA SPLICINGPROTEIN (Sulfolobussolfataricus) |
PF01798(Nop) | 3 | THR A 51GLU A 66HIS A 9 | None | 0.88A | 1xwfD-3id6A:undetectable | 1xwfD-3id6A:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ixw | HEMOCYANIN AA6 CHAIN (Androctonusaustralis) |
PF00372(Hemocyanin_M)PF03722(Hemocyanin_N)PF03723(Hemocyanin_C) | 3 | THR A 43GLU A 55HIS A 49 | None | 0.86A | 1xwfD-3ixwA:undetectable | 1xwfD-3ixwA:20.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jav | INOSITOL1,4,5-TRISPHOSPHATERECEPTOR TYPE 1 (Rattusnorvegicus) |
PF00520(Ion_trans)PF01365(RYDR_ITPR)PF02815(MIR)PF08454(RIH_assoc)PF08709(Ins145_P3_rec) | 3 | THR A2315GLU A2306HIS A2331 | None | 0.57A | 1xwfD-3javA:undetectable | 1xwfD-3javA:10.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jck | 26S PROTEASOMEREGULATORY SUBUNITRPN3 (Saccharomycescerevisiae) |
PF01399(PCI)PF08375(Rpn3_C) | 3 | THR A 262GLU A 258HIS A 225 | None | 0.70A | 1xwfD-3jckA:undetectable | 1xwfD-3jckA:18.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3k9d | ALDEHYDEDEHYDROGENASE (Listeriamonocytogenes) |
PF00171(Aldedh) | 3 | THR A 122GLU A 61HIS A 144 | CL A 465 (-4.1A)NoneNone | 0.86A | 1xwfD-3k9dA:4.9 | 1xwfD-3k9dA:22.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lg5 | EPI-ISOZIZAENESYNTHASE (Streptomycescoelicolor) |
no annotation | 3 | THR A 156GLU A 208HIS A 164 | NoneNoneSO4 A 705 (-3.9A) | 0.83A | 1xwfD-3lg5A:undetectable | 1xwfD-3lg5A:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3moz | MYO-INOSITOLHEXAPHOSPHATEPHOSPHOHYDROLASE (Selenomonasruminantium) |
PF14566(PTPlike_phytase) | 3 | THR A 259GLU A 136HIS A 224 | PO4 A 400 (-3.8A)None5IP A 401 (-3.8A) | 0.76A | 1xwfD-3mozA:undetectable | 1xwfD-3mozA:20.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n2x | UNCHARACTERIZEDPROTEIN YAGE (Escherichiacoli) |
PF00701(DHDPS) | 3 | THR A 36GLU A 59HIS A 283 | None | 0.89A | 1xwfD-3n2xA:undetectable | 1xwfD-3n2xA:23.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rj8 | CARBOHYDRATE OXIDASE (Microdochiumnivale) |
PF01565(FAD_binding_4)PF08031(BBE) | 3 | THR A 46GLU A 174HIS A 105 | None | 0.90A | 1xwfD-3rj8A:undetectable | 1xwfD-3rj8A:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3slt | SERINE PROTEASE ESPP (Escherichiacoli) |
PF03797(Autotransporter) | 3 | THR A1083GLU A1021HIS A1086 | None | 0.89A | 1xwfD-3sltA:undetectable | 1xwfD-3sltA:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t1i | DOUBLE-STRAND BREAKREPAIR PROTEINMRE11A (Homo sapiens) |
PF00149(Metallophos)PF04152(Mre11_DNA_bind) | 3 | THR A 19GLU A 278HIS A 63 | None | 0.84A | 1xwfD-3t1iA:undetectable | 1xwfD-3t1iA:22.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t6q | CD180 ANTIGENLYMPHOCYTE ANTIGEN86 (Mus musculus) |
PF02221(E1_DerP2_DerF2)PF13855(LRR_8) | 3 | THR A 306GLU C 103HIS A 379 | NoneMAN A 806 (-3.0A)MAN A 806 ( 4.0A) | 0.83A | 1xwfD-3t6qA:undetectable | 1xwfD-3t6qA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tpf | ORNITHINECARBAMOYLTRANSFERASE (Campylobacterjejuni) |
PF00185(OTCace)PF02729(OTCace_N) | 3 | THR A 219GLU A 284HIS A 124 | None | 0.90A | 1xwfD-3tpfA:8.9 | 1xwfD-3tpfA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tr5 | PEPTIDE CHAINRELEASE FACTOR 3 (Coxiellaburnetii) |
PF00009(GTP_EFTU)PF16658(RF3_C) | 3 | THR A 101GLU A 279HIS A 131 | None | 0.73A | 1xwfD-3tr5A:undetectable | 1xwfD-3tr5A:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tx8 | SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE (Corynebacteriumglutamicum) |
PF01546(Peptidase_M20)PF07687(M20_dimer) | 3 | THR A 19GLU A 349HIS A 77 | None | 0.82A | 1xwfD-3tx8A:undetectable | 1xwfD-3tx8A:22.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3u9s | METHYLCROTONYL-COACARBOXYLASE,ALPHA-SUBUNIT (Pseudomonasaeruginosa) |
PF00289(Biotin_carb_N)PF00364(Biotin_lipoyl)PF02785(Biotin_carb_C)PF02786(CPSase_L_D2) | 3 | THR A 351GLU A 273HIS A 380 | None | 0.83A | 1xwfD-3u9sA:6.1 | 1xwfD-3u9sA:20.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vsv | XYLOSIDASE (Thermoanaerobacteriumsaccharolyticum) |
PF13229(Beta_helix) | 3 | THR A 8GLU A 69HIS A 4 | None | 0.62A | 1xwfD-3vsvA:undetectable | 1xwfD-3vsvA:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vu2 | 1,4-ALPHA-GLUCAN-BRANCHING ENZYME,CHLOROPLASTIC/AMYLOPLASTIC (Oryza sativa) |
PF00128(Alpha-amylase)PF02806(Alpha-amylase_C)PF02922(CBM_48) | 3 | THR A 559GLU A 193HIS A 532 | None | 0.83A | 1xwfD-3vu2A:undetectable | 1xwfD-3vu2A:20.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vvd | AMINO ACID ABCTRANSPORTER, BINDINGPROTEIN (Thermusthermophilus) |
PF00497(SBP_bac_3) | 3 | THR A 98GLU A 38HIS A 79 | None | 0.86A | 1xwfD-3vvdA:undetectable | 1xwfD-3vvdA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vys | HYDROGENASEEXPRESSION/FORMATIONPROTEIN HYPD (Thermococcuskodakarensis) |
PF01924(HypD) | 3 | THR B 180GLU B 359HIS B 202 | None | 0.90A | 1xwfD-3vysB:undetectable | 1xwfD-3vysB:22.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w2z | METHYL-ACCEPTINGCHEMOTAXIS PROTEIN (Nostoc sp. PCC7120) |
PF01590(GAF) | 3 | THR A 170GLU A 163HIS A 20 | None | 0.88A | 1xwfD-3w2zA:undetectable | 1xwfD-3w2zA:20.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zx1 | OXIDOREDUCTASE,PUTATIVE (Campylobacterjejuni) |
PF00394(Cu-oxidase)PF07731(Cu-oxidase_2)PF07732(Cu-oxidase_3) | 3 | THR A 137GLU A 501HIS A 141 | NoneOXY A 605 ( 4.3A) CU A 602 (-3.0A) | 0.56A | 1xwfD-3zx1A:undetectable | 1xwfD-3zx1A:22.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c9m | CYTOCHROME P450 (Novosphingobiumaromaticivorans) |
PF00067(p450) | 3 | THR A 376GLU A 294HIS A 369 | None | 0.64A | 1xwfD-4c9mA:undetectable | 1xwfD-4c9mA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dg8 | PA1221 (Pseudomonasaeruginosa) |
PF00501(AMP-binding) | 3 | THR A 258GLU A 451HIS A 290 | BU3 A 703 (-3.7A)NoneNone | 0.86A | 1xwfD-4dg8A:3.5 | 1xwfD-4dg8A:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4eqm | PROTEIN KINASE (Staphylococcusaureus) |
PF00069(Pkinase) | 3 | THR A 186GLU A 58HIS A 131 | None | 0.86A | 1xwfD-4eqmA:undetectable | 1xwfD-4eqmA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fo7 | METHIONINEAMINOPEPTIDASE (Pseudomonasaeruginosa) |
PF00557(Peptidase_M24) | 3 | THR A 98GLU A 203HIS A 79 | None MN A 301 (-2.7A)None | 0.65A | 1xwfD-4fo7A:undetectable | 1xwfD-4fo7A:20.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h6x | THIAZOLINEOXIDASE/SUBTILISIN-LIKE PROTEASE (Prochlorondidemni) |
PF00082(Peptidase_S8) | 3 | THR A 743GLU A 764HIS A 746 | None | 0.86A | 1xwfD-4h6xA:undetectable | 1xwfD-4h6xA:22.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hg0 | MAGNESIUM AND COBALTEFFLUX PROTEIN CORC (Escherichiacoli) |
PF00571(CBS)PF03471(CorC_HlyC) | 3 | THR A 213GLU A 191HIS A 210 | None | 0.84A | 1xwfD-4hg0A:undetectable | 1xwfD-4hg0A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jo0 | CMLA (Streptomycesvenezuelae) |
PF12706(Lactamase_B_2) | 3 | THR A 175GLU A 171HIS A 69 | None | 0.82A | 1xwfD-4jo0A:undetectable | 1xwfD-4jo0A:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k92 | CLIP-ASSOCIATINGPROTEIN 1 (Homo sapiens) |
PF12348(CLASP_N) | 3 | THR A 477GLU A 520HIS A 514 | None | 0.86A | 1xwfD-4k92A:undetectable | 1xwfD-4k92A:19.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m0x | CHLOROMUCONATECYCLOISOMERASE (Rhodococcusopacus) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 3 | THR A 52GLU A 64HIS A 30 | None | 0.87A | 1xwfD-4m0xA:undetectable | 1xwfD-4m0xA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m6r | METHYLTHIORIBULOSE-1-PHOSPHATEDEHYDRATASE (Homo sapiens) |
PF00596(Aldolase_II) | 3 | THR A 203GLU A 22HIS A 52 | None | 0.85A | 1xwfD-4m6rA:undetectable | 1xwfD-4m6rA:18.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mv3 | BIOTIN CARBOXYLASE (Haemophilusinfluenzae) |
PF00289(Biotin_carb_N)PF02785(Biotin_carb_C)PF02786(CPSase_L_D2) | 3 | THR A 304GLU A 227HIS A 333 | None | 0.85A | 1xwfD-4mv3A:undetectable | 1xwfD-4mv3A:21.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nx8 | PROTEIN-TYROSINEPHOSPHATASE 2 (Bdellovibriobacteriovorus) |
PF14566(PTPlike_phytase) | 3 | THR A 213GLU A 103HIS A 178 | None | 0.86A | 1xwfD-4nx8A:1.9 | 1xwfD-4nx8A:19.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oe7 | PROBABLE2-KETO-3-DEOXY-GALACTONATE ALDOLASE YAGE (Escherichiacoli) |
PF00701(DHDPS) | 3 | THR A 36GLU A 59HIS A 283 | None | 0.91A | 1xwfD-4oe7A:undetectable | 1xwfD-4oe7A:23.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qtb | MITOGEN-ACTIVATEDPROTEIN KINASE 3 (Homo sapiens) |
PF00069(Pkinase) | 3 | THR A 347GLU A 351HIS A 195 | EDO A 406 (-3.7A)NoneNone | 0.64A | 1xwfD-4qtbA:undetectable | 1xwfD-4qtbA:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r1d | UNCHARACTERIZEDPROTEIN (Pseudomonasaeruginosa) |
no annotation | 3 | THR A 502GLU A 182HIS A 519 | None | 0.88A | 1xwfD-4r1dA:undetectable | 1xwfD-4r1dA:21.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yke | MRE11 (Chaetomiumthermophilum) |
PF00149(Metallophos)PF04152(Mre11_DNA_bind) | 3 | THR A 16GLU A 274HIS A 60 | None | 0.68A | 1xwfD-4ykeA:undetectable | 1xwfD-4ykeA:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a6b | N-ACETYL-BETA-D-GLUCOSAMINIDASE (Streptococcuspneumoniae) |
PF00728(Glyco_hydro_20) | 3 | THR D 159GLU D 367HIS D 262 | None | 0.84A | 1xwfD-5a6bD:undetectable | 1xwfD-5a6bD:19.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cl2 | SPORULATION-CONTROLPROTEIN SPO0M (Bacillussubtilis) |
PF07070(Spo0M) | 3 | THR A 98GLU A 199HIS A 137 | None | 0.80A | 1xwfD-5cl2A:undetectable | 1xwfD-5cl2A:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e9g | ISOCITRATE LYASE (Magnaportheoryzae) |
PF00463(ICL) | 3 | THR A 91GLU A 501HIS A 511 | None | 0.84A | 1xwfD-5e9gA:undetectable | 1xwfD-5e9gA:23.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e9h | ISOCITRATE LYASE (Fusariumgraminearum) |
PF00463(ICL) | 3 | THR A 91GLU A 500HIS A 510 | None | 0.78A | 1xwfD-5e9hA:undetectable | 1xwfD-5e9hA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eco | JASMONIC ACID-AMIDOSYNTHETASE JAR1 (Arabidopsisthaliana) |
PF03321(GH3) | 3 | THR A 233GLU A 480HIS A 225 | None | 0.88A | 1xwfD-5ecoA:undetectable | 1xwfD-5ecoA:21.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h9f | CRISPR SYSTEMCASCADE SUBUNIT CASC (Escherichiacoli) |
PF09344(Cas_CT1975) | 3 | THR D 260GLU D 351HIS D 253 | None | 0.90A | 1xwfD-5h9fD:undetectable | 1xwfD-5h9fD:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i4q | CONTACT-DEPENDENTINHIBITOR IELONGATION FACTOR TU (Escherichiacoli) |
PF03143(GTP_EFTU_D3)PF03144(GTP_EFTU_D2)no annotation | 3 | THR C 341GLU B 6HIS C 365 | None | 0.60A | 1xwfD-5i4qC:undetectable | 1xwfD-5i4qC:19.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ivw | GENERALTRANSCRIPTION FACTORIIH SUBUNIT 3 (Homo sapiens) |
PF03850(Tfb4) | 3 | THR 3 120GLU 3 66HIS 3 128 | None | 0.90A | 1xwfD-5ivw3:undetectable | 1xwfD-5ivw3:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jfm | ALDEHYDEDEHYDROGENASE (Rhodopseudomonaspalustris) |
PF00171(Aldedh) | 3 | THR A 201GLU A 143HIS A 223 | NoneNone1VU A 601 (-3.9A) | 0.90A | 1xwfD-5jfmA:4.6 | 1xwfD-5jfmA:23.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5joz | NON-REDUCING ENDALPHA-L-ARABINOFURANOSIDASE BOGH43B (Bacteroidesovatus) |
PF04616(Glyco_hydro_43) | 3 | THR A 447GLU A 408HIS A 420 | None | 0.85A | 1xwfD-5jozA:undetectable | 1xwfD-5jozA:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n4l | CERULOPLASMIN (Rattusnorvegicus) |
no annotation | 3 | THR A1028GLU A 112HIS A 972 | None CA A1106 (-4.7A) CU A1105 (-3.3A) | 0.89A | 1xwfD-5n4lA:undetectable | 1xwfD-5n4lA:11.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nzg | UDP-GLUCOSEPYROPHOSPHORYLASE (Leishmaniamajor) |
no annotation | 3 | THR A 461GLU A 251HIS A 410 | NoneEDO A 609 (-4.8A)EDO A 609 (-3.1A) | 0.88A | 1xwfD-5nzgA:undetectable | 1xwfD-5nzgA:12.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5odr | HETERODISULFIDEREDUCTASE, SUBUNIT A (Methanothermococcusthermolithotrophicus) |
PF07992(Pyr_redox_2)PF13187(Fer4_9) | 3 | THR A 287GLU A 263HIS A 292 | None | 0.80A | 1xwfD-5odrA:5.2 | 1xwfD-5odrA:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t1d | GLYCOPROTEIN 42 (Humangammaherpesvirus4) |
no annotation | 3 | THR C 84GLU C 207HIS C 191 | None | 0.79A | 1xwfD-5t1dC:undetectable | 1xwfD-5t1dC:17.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tjr | METHYLMALONATE-SEMIALDEHYDEDEHYDROGENASE (Pseudomonas sp.AAC) |
PF00171(Aldedh) | 3 | THR A 2GLU A 89HIS A 202 | None | 0.78A | 1xwfD-5tjrA:3.6 | 1xwfD-5tjrA:23.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5tov | ADENOSYLHOMOCYSTEINASE (Thermotogamaritima) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 3 | THR A 46GLU A 139HIS A 336 | None | 0.83A | 1xwfD-5tovA:38.7 | 1xwfD-5tovA:40.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uz5 | PRE-MRNA-PROCESSINGFACTOR 39 (Saccharomycescerevisiae) |
no annotation | 3 | THR E 566GLU E 579HIS E 563 | None | 0.79A | 1xwfD-5uz5E:undetectable | 1xwfD-5uz5E:21.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vgz | 26S PROTEASOMEREGULATORY SUBUNIT 426S PROTEASOMEREGULATORY SUBUNIT 8 (Homo sapiens) |
no annotation | 3 | THR B 111GLU C 92HIS B 131 | None | 0.79A | 1xwfD-5vgzB:undetectable | 1xwfD-5vgzB:11.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsl | RADICAL S-ADENOSYLMETHIONINEDOMAIN-CONTAININGPROTEIN 2 (Mus musculus) |
PF04055(Radical_SAM)PF13353(Fer4_12) | 3 | THR A 97GLU A 257HIS A 79 | None | 0.77A | 1xwfD-5vslA:undetectable | 1xwfD-5vslA:21.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w94 | MAU2 CHROMATIDCOHESION FACTORHOMOLOG (Saccharomycescerevisiae) |
PF10345(Cohesin_load) | 3 | THR A 359GLU A 352HIS A 297 | None | 0.90A | 1xwfD-5w94A:undetectable | 1xwfD-5w94A:21.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wy4 | PUTATIVEUNCHARACTERIZEDPROTEIN (Chaetomiumthermophilum) |
no annotation | 3 | THR A 150GLU A 119HIS A 128 | None | 0.83A | 1xwfD-5wy4A:undetectable | 1xwfD-5wy4A:12.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xqo | PCRGLX PROTEIN (Penicilliumchrysogenum) |
no annotation | 3 | THR A 858GLU A 825HIS A 820 | None | 0.88A | 1xwfD-5xqoA:undetectable | 1xwfD-5xqoA:11.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z2g | L-AMINO ACID OXIDASE (Naja atra) |
no annotation | 3 | THR A 488GLU A 32HIS A 114 | None | 0.80A | 1xwfD-5z2gA:undetectable | 1xwfD-5z2gA:11.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 3 | THR A 63GLU A 161HIS A 358 | ADN A 501 (-4.5A)ADN A 501 (-2.5A)ADN A 501 ( 3.5A) | 0.82A | 1xwfD-6aphA:57.2 | 1xwfD-6aphA:66.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bng | 2-DEHYDRO-3-DEOXYPHOSPHOOCTONATEALDOLASE (Acinetobacterbaumannii) |
no annotation | 3 | THR A 126GLU A 161HIS A 154 | None | 0.90A | 1xwfD-6bngA:undetectable | 1xwfD-6bngA:11.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6chd | LYSINE--TRNA LIGASE (Homo sapiens) |
no annotation | 3 | THR A 337GLU A 494HIS A 331 | KAA A 601 (-4.4A)KAA A 601 (-3.0A)KAA A 601 (-4.2A) | 0.87A | 1xwfD-6chdA:undetectable | 1xwfD-6chdA:13.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6d6q | EXOSOME COMPLEXEXONUCLEASE RRP44 (Homo sapiens) |
no annotation | 3 | THR K 262GLU K 289HIS K 266 | None | 0.89A | 1xwfD-6d6qK:undetectable | 1xwfD-6d6qK:10.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6erc | PEROXINECTIN A (Dictyosteliumdiscoideum) |
no annotation | 3 | THR A 293GLU A 327HIS A 464 | NoneHEM A 604 (-3.8A)None | 0.76A | 1xwfD-6ercA:undetectable | 1xwfD-6ercA:11.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6etz | BETA-GALACTOSIDASE (Arthrobactersp. 32cB) |
no annotation | 3 | THR A 444GLU A 467HIS A 395 | None | 0.45A | 1xwfD-6etzA:undetectable | 1xwfD-6etzA:11.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6evg | MULTI-COPPER OXIDASECUEO (Ochrobactrum) |
no annotation | 3 | THR A 89GLU A 496HIS A 93 | None | 0.77A | 1xwfD-6evgA:undetectable | 1xwfD-6evgA:12.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f0k | POLYSULPHIDEREDUCTASE NRFD (Rhodothermusmarinus) |
no annotation | 3 | THR C 315GLU C 394HIS C 247 | None | 0.91A | 1xwfD-6f0kC:undetectable | 1xwfD-6f0kC:10.38 |